Skip to main content
RecallRadar
FDAClass II

Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for:… Recalled: Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.

Abirtega (abiraterone acetate) USP, 250 mg, 120-count… was recalled on October 6, 2026 in cooperation with the U.S. Food and Drug Administration because failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity..

Is my unit affected?

Abirtega (abiraterone acetate) USP, 250 mg, 120-count bottles, Rx only, Rx only, Mfd for: Hikma Pharmaceuticals USA Inc., Berkley Heights, NJ 07922 USA by: Arab Pharmaceuticals Manufacturing PSC PO Box 41, Sahab-Jordon, NDC 82249-011-12.

Model, lot & date codes to check

Lot #: 3047, Exp Date July 2027.

Units affected: 2136 bottles

Where it was sold: Nationwide within the United States

Compare the codes above against the label on your product — usually on the bottom, the back panel, or the packaging. If your unit isn't listed, it is not part of this recall.

What's the hazard?

Failed Tablet/Capsule Specifications: Failed tablet specifications for weight uniformity.

Class II means the product might cause a temporary or medically reversible health problem; the chance of serious harm is remote.

Your remedy & how to claim it

Stop using the product. Return it to the place of purchase for a refund, or dispose of it. Contact the recalling firm with questions.

Contact: Recalling firm: Hikma Pharmaceuticals USA INC.

Not sure what you're entitled to? Read our guide: what to do if your product is recalled.

Official recall notice

Always confirm details on the official notice from the U.S. Food and Drug Administration before acting.

View official notice →

Get recall alerts

Be the first to know when products like this are recalled. Free weekly digest, unsubscribe anytime.

Double opt-in: we only email you after you confirm. No spam, ever.